Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Comabella

Showing results (51-60 of 83) with videos related to

Pageof 9
Sort By:
European Journal of Neurology|May 26, 2018
Cognitive impairment in early stages of multiple sclerosis is associated with high cerebrospinal fluid levels of chitinase 3-like 1 and neurofilament light chainE Quintana, C Coll, J Salavedra-Pont, et al.
Journal of the Neurological Sciences|January 28, 2025
Usefulness of serum neurofilament light chain in chronic inflammatory demyelinating polyradiculoneuropathyA Llauradó, C García-Carmona, J L Restrepo-Vera, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 7, 2013
Early detection of neutralizing antibodies to interferon-beta in multiple sclerosis patients: binding antibodies predict neutralizing antibody developmentH Hegen, A Millonig, A Bertolotto, et al.
Genes and Immunity|July 1, 2011
A cytokine gene screen uncovers SOCS1 as genetic risk factor for multiple sclerosisK Vandenbroeck, J Alvarez, B Swaminathan, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 21, 2011
Chitinase 3-like 1 plasma levels are increased in patients with progressive forms of multiple sclerosisE Cantó, F Reverter, C Morcillo-Suárez, et al.
Genes and Immunity|December 2, 2011
ANKRD55 and DHCR7 are novel multiple sclerosis risk lociI Alloza, D Otaegui, A Lopez de Lapuente, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 2, 2019
The genetic diversity of multiple sclerosis risk among Hispanic and African American populations living in the United StatesA H Beecham, L Amezcua, A Chinea, et al.
Genes and Immunity|October 15, 2010
Replication of top markers of a genome-wide association study in multiple sclerosis in SpainM L Cavanillas, O Fernández, M Comabella, et al.
Revista De Neurologia|July 22, 2016
[Response to treatment with interferon beta in patients with multiple sclerosis. Validation of the Rio Score]J Rio, A Rovira, Y Blanco, et al.
Genes and Immunity|May 29, 2010
The autoimmune disease-associated KIF5A, CD226 and SH2B3 gene variants confer susceptibility for multiple sclerosisA Alcina, K Vandenbroeck, D Otaegui, et al.
Pageof 9

Showing results (51-60 of 83) with videos related to

Sort By:
Pageof 9
European Journal of Neurology|May 26, 2018
Cognitive impairment in early stages of multiple sclerosis is associated with high cerebrospinal fluid levels of chitinase 3-like 1 and neurofilament light chainE Quintana, C Coll, J Salavedra-Pont, et al.
Journal of the Neurological Sciences|January 28, 2025
Usefulness of serum neurofilament light chain in chronic inflammatory demyelinating polyradiculoneuropathyA Llauradó, C García-Carmona, J L Restrepo-Vera, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 7, 2013
Early detection of neutralizing antibodies to interferon-beta in multiple sclerosis patients: binding antibodies predict neutralizing antibody developmentH Hegen, A Millonig, A Bertolotto, et al.
Genes and Immunity|July 1, 2011
A cytokine gene screen uncovers SOCS1 as genetic risk factor for multiple sclerosisK Vandenbroeck, J Alvarez, B Swaminathan, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 21, 2011
Chitinase 3-like 1 plasma levels are increased in patients with progressive forms of multiple sclerosisE Cantó, F Reverter, C Morcillo-Suárez, et al.
Genes and Immunity|December 2, 2011
ANKRD55 and DHCR7 are novel multiple sclerosis risk lociI Alloza, D Otaegui, A Lopez de Lapuente, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 2, 2019
The genetic diversity of multiple sclerosis risk among Hispanic and African American populations living in the United StatesA H Beecham, L Amezcua, A Chinea, et al.
Genes and Immunity|October 15, 2010
Replication of top markers of a genome-wide association study in multiple sclerosis in SpainM L Cavanillas, O Fernández, M Comabella, et al.
Revista De Neurologia|July 22, 2016
[Response to treatment with interferon beta in patients with multiple sclerosis. Validation of the Rio Score]J Rio, A Rovira, Y Blanco, et al.
Genes and Immunity|May 29, 2010
The autoimmune disease-associated KIF5A, CD226 and SH2B3 gene variants confer susceptibility for multiple sclerosisA Alcina, K Vandenbroeck, D Otaegui, et al.
Pageof 9